Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndrome
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63608 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Suzanne P MacFarland und 12 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Phenotype, Hamartoma Syndrome, Multiple, Autism Spectrum Disorder, PTEN Phosphohydrolase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Center for Advancing Translational Sciences, National Institutes of Health, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Our study characterized the neurodevelopmental spectrum of individuals with PTEN Hamartoma Tumor Syndrome (PHTS), a syndrome that predisposes to both neurodevelopmental phenotypes and cancer risk. We aim to better understand life‐impacting neurodevelopmental features of PHTS. Our study recruited 20 children/adolescents with PHTS, who were then administered assessments for autism spectrum disorder (ASD) and other neurocognitive measures, including assessment of IQ, executive and adaptive functioning, and health‐related quality of life. Thirteen individuals (65%) were identified as having ASD, of which five were newly diagnosed during the study. Of those, ASD symptom severity was in the mild–moderate range for 77%. Overall, IQ was in the average range, with a mean of 92.61 ( SD 24.45, p = 0.5), though there was a non‐statistically significant trend toward individuals without ASD having a higher mean IQ (102.7 vs 82.3; p = 0.1). Subjects had significant impairment in processing speed (mean 75.38, SD 24.75, p < 0.05), decreased adaptive functioning skills across all domains, and a trend toward having more executive functioning problems. Individuals with PHTS are at increased risk of neurodevelopmental disorders, including ASD and impaired executive and adaptive functioning. Although clear guidelines exist for cancer surveillance for individuals with PHTS, additional guidelines and screening for neurodevelopmental disorders are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Eastern Virginia Medical School, Norfolk, Virginia, USA.
- Behavioral Neuroscience Core, Center for Human Phenomic Science, The Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, USA.
- Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA.
ORCID-Profile: Suzanne P MacFarland
Förderung
- National Center for Advancing Translational Sciences, National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
MacFarland, S. P., Duvall, M., Kemajou, R. T., Baldino, S. E., Zelley, K., Black, C., Thomas, A., Thomas, N. H., Ruffner, M., Li, Y., Miller, J. S., Brodeur, G. M., & Shabason, E. (2024). Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63608
Vancouver
MacFarland SP, Duvall M, Kemajou RT, Baldino SE, Zelley K, Black C, et al. Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndrome. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63608
BibTeX
@article{MacFarland2024,
author = {MacFarland, Suzanne P and Duvall, Melani and Kemajou, Raissa Tchetcho and Baldino, Sarah E and Zelley, Kristin and Black, Chelsea and Thomas, Allison and Thomas, Nina H and Ruffner, Melanie and Li, Yimei and Miller, Judith S and Brodeur, Garrett M and Shabason, Emily},
title = {Developmental and behavioral phenotypes of pediatric patients with PTEN hamartoma tumor syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63608}
}
EUVIMED